Roehrhoff to succeed Herberg as Gerresheimer ceo

Company: Gerresheimer

Gerresheimer\'s chief executive Axel Herberg will step down and leave the company\'s management board when his contract expires in June. His successor will be Uwe Roehrhoff.

Gerresheimer's chief executive Axel Herberg will step down and leave the company's management board when his contract expires in June. His successor will be Uwe Roehrhoff. Herberg has spent nearly 20 years in top management with Gerresheimer. In the past 10 years as ceo he has shaped the Duesseldorf company's development into an international supplier of glass and plastic vials and drug delivery systems to the pharma and healthcare industries. He was also instrumental in the successful flotation of Gerresheimer AG. Herberg has worked with his successor for many years. Roehrhoff has also been with Gerresheimer for 20 years. He was appointed to the management board in 2003 and took responsibility for the development of Gerresheimer's business in the US and China. Gerresheimer has also appointed Hans-Juergen Wiecha as chief financial officer for a further five years.

You may also like

Drug Delivery

Gerresheimer's Gx Inbeneo wins Red Dot award

The company's autoinjector allows patients to effectively self-administer biologics in the comfort of their own home
Manufacturing

SCHOTT, Gerresheimer and Stevanato Group form the 'Alliance for RTU'

The scheme will promote the adoption of ready-to-use (RTU) vials and cartridges for CDMOs in the injectable scene
Drug Delivery

Meet the experts, watch the presentation, join the after show party at booth 20B1!

Visit our booth, browse our comprehensive product range or talk to our experts. Get insights on how we could support you with our best-in-class containment solutions and innovative drug delivery devices at CPHI in Milan
Drug Delivery

Gerresheimer presents prefillable ophthalmic syringe solutions at CPHI 2024

The syringes are compatible with sensitive drug formats, while also containing no silicone oil
Drug Delivery

Aptar Digital Health and Gerresheimer collaborate to develop integrated solution for subcutaneous cancer therapy

Collaboration aims to deliver an innovative solution to improve overall patient treatment adherence and clinical outcomes
Drug Delivery

Gerresheimer enters joint venture with Corning

The partnership will combine Gerresheimer’s extensive glass converting expertise with Corning’s innovative Velocity Vial technology
Drug Delivery

ISR signs agreement with Gerresheimer for clinical-scale production of IcoOne nasal inhalers

The drug development company ISR has signed an agreement with Gerresheimer for large-scale production of the IcoOne nasal inhaler, for its phase III study of its dry powder Covid-19 vaccine
Subscribe now